Kerry acquires Canadian probiotic company
Bio-K Plus is a probiotic company with a range of clinically-supported probiotic beverage and supplement applications in the North American market and will expand Kerry’s capabilities and leadership position in the probiotics market.
The acquisition expands Kerry’s portfolio of probiotics. Bio-K Plus products are formulated with three proprietary and clinically validated strains of probiotics that have confirmed efficacy for a range of therapeutic benefits, including the prevention of side effects resulting from antibiotic use.
Neil Cracknell, president Kerry Applied Health & Nutrition, said, “We are committed to creating a world of sustainable nutrition and this acquisition will support our ambition to reach over two billion people with sustainable nutrition solutions by 2030.
“Research has shown that consumers are increasingly looking for nutritional benefits when purchasing food and drink and that products which contain probiotics that improve gut health are specifically in demand.”
Kerry has been developing its position in science-backed functional ingredients for several years, with the acquisition of immune health ingredient Wellmune in 2015, followed by the probiotic GanedenBC30 in 2017.
Headquartered in Québec, Canada, Bio-K Plus develops, manufactures, and distributes clinically supported probiotic fermented beverages and supplements under the Bio-K Plus brand throughout North America. The company has 134 employees and operates two facilities, one in Québec, and the second in California.
